Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-27 22:48:56 - browse：6

Alnylam headquarters — Kristoffer Tripplaar/Sipa USA/AP

A group of advisers to the Food and Drug Administration voted in favor of Alnylam Pharmaceuticals’ treatment for a debilitating heart disease Wednesday, but only after a day-long debate challenging whether the drug’s modest observed effects were actually meaningful for patients.

The group of independent experts voted 9-3 that the benefits of Alnylam’s drug, called patisiran, outweighed its risks for patients with ATTR-CM, a progressive disease that leads to fatal heart failure if left untreated. The FDA, which is not required to follow the advice of advisers, is expected to make a final decision on patisiran by Oct. 8.

“It’s like a light wind blowing in favor of patisiran over placebo,” said David Cella, a neurologist at the Northwestern University Feinberg School of Medicine who voted in favor of patisiran. David Moliterno, a cardiologist at the University of Kentucky, added that “the good news in this story is that while there may be a small benefit, it doesn’t look like there’s a signal for harm.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Juul documents reveal insider tactics on political lobbying

WSS

Having children helps parents live longer, especially after age 80

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

AMAs digital advisors table RPM coding reform proposal, again

Congressmen charge Covid hearing ‘could have been an email’

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Why don't Americans have at

leisure time

Wikipedia

explore

Medicare details structure of new drug price negotiation program

Study gives hint on South Asians’ higher risk of cardiovascular disease

23andMe had bad news about my health. I wish a person had delivered it

Covid misinformation case heads to Supreme Court

Trump demands the U.S. pay no more for drugs than other countries … again

Eli Lilly reports tirzepatide MASH success during Q4 earnings

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

SAMSHA loosens regulations on methadone treatment centers

Psychedelics group wrestles with new pharma identity

Latigo launches with $135 million for Vertex

focus

Readout Newsletter: Amylyx, Aurinia, and IQVIA

Congress must protect the remaining independent doctors

Too many hospitalized Covid

Vertex non

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

hotspot

hotspot

knowledge

hotspot